{
    "key": "2013-0487",
    "name": "#1 @ 11 yrs, 0 days, MCV4",
    "cdcTestId": "2013-0487",
    "changedInVersion": "1.6",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2017-11-15T07:12:40.646",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "114",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            }
        ],
        "seriesStatus": "Not complete"
    },
    "evaluationTestType": "Age: At Minimum",
    "forecast": {
        "earliestDate": "2025-08-13T00:00:00",
        "forecastNum": "2",
        "pastDueDate": "2026-09-09T00:00:00",
        "recommendedDate": "2025-08-13T00:00:00"
    },
    "forecastTestType": "Recommended based on age",
    "generalDescription": "This test case describes when dose 1 of a Mening vaccine is given at 11 years that the dose is considered to be valid.",
    "patient": {
        "dob": "2009-08-13T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "114",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            }
        ]
    },
    "reasonForChange": "v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.",
    "testcaseName": "#1 @ 11 yrs, 0 days, MCV4",
    "vaccineGroup": "MCV"
}